| WHO Attempts To Reassure Skeptical
Public on H1N1 Vaccine Safety Issues
The World Health Organization (WHO) restated its confidence
in the H1N1 flu vaccine, calling it the most important tool against
the pandemic.
Despite widespread accusations which showed a plethora of contradictions
in WHO pandemic statements and policies, the international
health agency asserted their position with claims that "mild
adverse side effects such as muscle cramps or headache are to
be expected in some cases, but everyone who has access to the
vaccine should be inoculated."
Mass vaccination campaigns against the swine flu virus are underway
in China and Australia and will be starting soon in the United
States and parts of Europe, WHO spokesman Gregory Hartl said.
"It is important to remember that the vaccines, which have
already been approved, have been used for years and years and
years in their seasonal vaccine formulation and have been shown
to be among the safest vaccines that exist," he told a news
briefing.
The misguided reassurances from WHO are attempting to discredit
hundreds of independent and credible investigations which showed
that the Center of Disease Control (CDC) and the WHO
have been orchestrating the pandemic flu campaign from day
one. It is the WHO for "years and years" has been convincing
the public that a harmless flu is a greater risk to public health
than any vaccine. In actuality, the reverse is true (see the
H1N1 vaccine is a much great risk to your health than the flu
itself).
Last month, Dr. Leonard G. Horowitz, a world leading drug-industry
investigator launched
a well-documented investigation and subsequent legal affidavit
on the circumstances concerning the evidence and politically explosive
issues raised by discoveries into the H1N1 swine flu.
According to the affidavit, the United Nations’ and the WHO
are directly involved in the serological testing of vaccine trials;
the preparation and distribution of influenza viruses to vaccine
manufacturers; and the coordination of EU strain selection process
(ie., the selection of viruses that shall be used by governments
worldwide, and their “vaccine pipelines.")
Hartl, asked whether WHO was concerned by reports that some people
were reluctant to be injected with the new vaccine, said:
"Certainly we have seen the reports. Again, we would restate
that the most important tool that we have to fight this pandemic
is the vaccine."
It was doubly important that health care workers be vaccinated,
as it protects them as well as patients, he added.
"We would hope that everyone who has a chance to get vaccinated
does get vaccinated," Hartl told Reuters.
Since late spring, governments around the world have been telling
administrators of large facilities such as hospitals, schools
and community centres, to prepare
for mass vaccination programs set to be instituted in the
fall.
The United Nations agency declared in June that the H1N1 virus
was causing an influenza pandemic and its collaborating laboratories
have provided seed virus to drug makers worldwide to develop vaccines.
GlaxoSmithKline
won a further 22 government orders for its H1N1 swine flu vaccine
in the last two months, taking the total number of doses ordered
to 440 million worth some $3.5 billion. Rivals in flu vaccines
include Sanofi-Aventis,
Novartis,
Baxter,
AstraZeneca
and CSL.
A full list of h1n1 vaccine ingredients,
alerts and warnings from the companies themselves is
available
here.
 ...............................................................................................................
|
